DESONIDE

DESONIDE was reported 5061 times

DESONIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IRIDOSCHISIS 4 0.5714
1 VAGINAL FLATULENCE 152 0.5017
2 TOPICAL STEROID WITHDRAWAL REACTION 37 0.0951
3 FEMALE GENITAL TRACT FISTULA 160 0.0936
4 MACULAR DEGENERATION 787 0.0658
5 DIPHTHERIA 3 0.0638
6 RADICULOPATHY 159 0.0603
7 CHRONIC SINUSITIS 218 0.0580
8 PROCTITIS 152 0.0542
9 MUCOSAL PAIN 4 0.0476
10 GENITAL DISORDER 6 0.0448
11 ANHIDROSIS 17 0.0417
12 ECZEMA WEEPING 3 0.0229
13 PERIORBITAL INFLAMMATION 5 0.0216
14 TONGUE NEOPLASM 5 0.0209
15 FIBROUS HISTIOCYTOMA 7 0.0199
16 GINGIVAL EROSION 4 0.0155
17 VAGINAL DISCHARGE 154 0.0152
18 ECZEMA EYELIDS 8 0.0143
19 PARAESTHESIA ORAL 200 0.0139
20 CEREBRAL ARTERY THROMBOSIS 7 0.0136
21 STEROID WITHDRAWAL SYNDROME 13 0.0127
22 STEROID DEPENDENCE 11 0.0125
23 ORAL CANDIDIASIS 157 0.0119
24 EPIGLOTTIC OEDEMA 3 0.0114
25 GUTTATE PSORIASIS 9 0.0110
26 AVULSION FRACTURE 3 0.0105
27 INFLAMMATORY PAIN 7 0.0103
28 NAIL PITTING 4 0.0101
29 CUSHING'S SYNDROME 7 0.0101
30 NEUTRALISING ANTIBODIES POSITIVE 4 0.0096
31 MYCOBACTERIUM MARINUM INFECTION 3 0.0092
32 SEBORRHOEIC DERMATITIS 14 0.0085
33 DYSPLASTIC NAEVUS 3 0.0083
34 ECZEMA NUMMULAR 4 0.0082
35 BIOPSY LUNG 3 0.0082
36 LENTIGO 4 0.0081
37 CUTANEOUS T-CELL LYMPHOMA 9 0.0071
38 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 7 0.0066
39 PROCEDURAL PAIN 183 0.0066
40 ECZEMA HERPETICUM 3 0.0065
41 XEROSIS 8 0.0065
42 NASAL CRUSTING 4 0.0062
43 FREQUENT BOWEL MOVEMENTS 163 0.0060
44 SKIN OEDEMA 6 0.0060
45 SKIN WEEPING 21 0.0059
46 SJS-TEN OVERLAP 4 0.0057
47 GROIN INFECTION 3 0.0055
48 STARVATION 4 0.0048
49 PRECANCEROUS SKIN LESION 7 0.0047
50 DERMATITIS ATOPIC 250 0.0047
51 COLITIS 168 0.0044
52 TINEA PEDIS 7 0.0044
53 FALSE NEGATIVE INVESTIGATION RESULT 3 0.0043
54 ACTINIC KERATOSIS 11 0.0042
55 ANTIBODY TEST ABNORMAL 3 0.0042
56 CEREBELLAR INFARCTION 7 0.0041
57 EYELID SKIN DRYNESS 5 0.0041
58 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 70 0.0041
59 OTITIS EXTERNA 5 0.0041
60 OROPHARYNGEAL SWELLING 4 0.0041
61 RECTAL HAEMORRHAGE 174 0.0040
62 HYPERPARATHYROIDISM SECONDARY 10 0.0040
63 GINGIVAL ULCERATION 3 0.0040
64 EYELIDS PRURITUS 12 0.0038
65 SKIN PLAQUE 32 0.0038
66 COLITIS ULCERATIVE 167 0.0037
67 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 264 0.0037
68 MYCOSIS FUNGOIDES 3 0.0036
69 EYELID IRRITATION 9 0.0036
70 BLEPHARITIS 14 0.0035
71 SEBORRHOEIC KERATOSIS 5 0.0034
72 MELANOCYTIC NAEVUS 15 0.0034
73 NASAL DISORDER 9 0.0034
74 ANOGENITAL WARTS 3 0.0034
75 TOOTH EROSION 4 0.0033
76 ORAL MUCOSA EROSION 4 0.0033
77 HAEMATOCHEZIA 175 0.0032
78 ANTIPHOSPHOLIPID SYNDROME 5 0.0031
79 SKIN EROSION 10 0.0031
80 ANIMAL SCRATCH 3 0.0031
81 BICYTOPENIA 6 0.0031
82 NEPHROGENIC ANAEMIA 14 0.0030
83 INFUSION RELATED REACTION 200 0.0030
84 SKIN PAPILLOMA 12 0.0030
85 MYOCARDIAL NECROSIS MARKER INCREASED 5 0.0030
86 SKIN DISCOMFORT 8 0.0030
87 PUSTULE 7 0.0030
88 INTERVERTEBRAL DISC COMPRESSION 3 0.0029
89 DERMAL CYST 7 0.0028
90 SKIN HYPOPIGMENTATION 5 0.0028
91 CATAPLEXY 4 0.0028
92 WOUND SECRETION 11 0.0028
93 STAPHYLOCOCCAL BACTERAEMIA 12 0.0028
94 ECZEMA 143 0.0027
95 ESSENTIAL HYPERTENSION 5 0.0027
96 TEMPERATURE REGULATION DISORDER 6 0.0027
97 ESSENTIAL TREMOR 3 0.0027
98 IMPETIGO 4 0.0027
99 SKIN FISSURES 52 0.0027
100 REBOUND ACID HYPERSECRETION 8 0.0026
101 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
102 ARTERIAL HAEMORRHAGE 3 0.0026
103 MACROCYTOSIS 3 0.0026
104 EYE ALLERGY 4 0.0026
105 PAPULE 18 0.0026
106 HEPATIC LESION 11 0.0025
107 DERMATITIS 53 0.0025
108 SKIN HYPERTROPHY 7 0.0025
109 CONJUNCTIVITIS 46 0.0025
110 ACUTE SINUSITIS 4 0.0023
111 INFUSION SITE BRUISING 5 0.0023
112 APLASTIC ANAEMIA 12 0.0023
113 HERPES OPHTHALMIC 3 0.0023
114 ACROCHORDON 3 0.0023
115 MACULAR HOLE 3 0.0022
116 UTERINE POLYP 4 0.0022
117 SKIN HAEMORRHAGE 33 0.0022
118 AGORAPHOBIA 3 0.0022
119 PSORIASIS 284 0.0022
120 BLOOD THYROID STIMULATING HORMONE ABNORMAL 4 0.0022
121 ROSACEA 10 0.0021
122 STOMA SITE ERYTHEMA 4 0.0021
123 NECK MASS 6 0.0021
124 CONNECTIVE TISSUE DISORDER 3 0.0021
125 EYE PRURITUS 70 0.0021
126 SKIN SWELLING 18 0.0021
127 SWELLING OF EYELID 13 0.0021
128 DIABETES MELLITUS NON-INSULIN-DEPENDENT 3 0.0021
129 DYSPEPSIA 203 0.0021
130 PROSTATOMEGALY 8 0.0020
131 ERYTHEMA OF EYELID 11 0.0020
132 CONJUNCTIVITIS ALLERGIC 3 0.0020
133 BLOOD PRESSURE SYSTOLIC ABNORMAL 5 0.0020
134 SCAB 23 0.0020
135 SKIN EXFOLIATION 170 0.0020
136 AGE-RELATED MACULAR DEGENERATION 3 0.0020
137 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
138 PIGMENTATION DISORDER 12 0.0019
139 SENSITIVE SKIN 14 0.0019
140 NASAL ULCER 3 0.0019
141 HORDEOLUM 8 0.0018
142 EAR CONGESTION 5 0.0018
143 INFUSION SITE HAEMORRHAGE 6 0.0018
144 MADAROSIS 21 0.0018
145 ARTHROPOD STING 3 0.0018
146 EYE DISCHARGE 18 0.0017
147 EYELID MARGIN CRUSTING 5 0.0017
148 APPLICATION SITE DISCOLOURATION 7 0.0017
149 BURNS SECOND DEGREE 3 0.0017
150 KYPHOSIS 3 0.0017
151 BREAST CYST 3 0.0017
152 ODYNOPHAGIA 10 0.0017
153 RASH VESICULAR 8 0.0017
154 BODY TEMPERATURE ABNORMAL 3 0.0016
155 SKIN INFECTION 18 0.0016
156 PRE-EXISTING CONDITION IMPROVED 10 0.0016
157 ONYCHOMYCOSIS 7 0.0016
158 NARCOLEPSY 3 0.0016
159 AORTIC ARTERIOSCLEROSIS 4 0.0016
160 CUTANEOUS LUPUS ERYTHEMATOSUS 3 0.0015
161 ATROPHY 3 0.0015
162 ERYTHEMA 317 0.0015
163 LYMPHOCYTE COUNT INCREASED 5 0.0015
164 EXFOLIATIVE RASH 4 0.0015
165 ANXIETY DISORDER 5 0.0015
166 DERMATITIS CONTACT 17 0.0015
167 PSORIATIC ARTHROPATHY 60 0.0015
168 APPLICATION SITE DRYNESS 5 0.0015
169 IMMUNE-MEDIATED HEPATITIS 3 0.0015
170 RED BLOOD CELL COUNT INCREASED 4 0.0014
171 DRY SKIN 193 0.0014
172 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
173 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
174 LIP PAIN 4 0.0014
175 SKIN DISORDER 46 0.0014
176 OCULAR HYPERAEMIA 65 0.0014
177 LUMBAR SPINAL STENOSIS 4 0.0014
178 PERIPHERAL VASCULAR DISORDER 7 0.0014
179 DANDRUFF 3 0.0014
180 NEURODERMATITIS 5 0.0013
181 POLYARTHRITIS 7 0.0013
182 DRY EYE 66 0.0013
183 PARANASAL SINUS DISCOMFORT 5 0.0013
184 HAEMATOCRIT INCREASED 3 0.0013
185 KERATITIS 4 0.0013
186 ISCHAEMIC CARDIOMYOPATHY 4 0.0013
187 ECTOPIC PREGNANCY 4 0.0013
188 BLOOD PRESSURE DIASTOLIC INCREASED 6 0.0013
189 SYNOVIAL CYST 6 0.0013
190 NECK SURGERY 3 0.0013
191 ESCHERICHIA BACTERAEMIA 3 0.0013
192 NEURALGIA 31 0.0013
193 FURUNCLE 10 0.0013
194 POLYMYALGIA RHEUMATICA 4 0.0013
195 STREPTOCOCCAL INFECTION 7 0.0013
196 IMPAIRED QUALITY OF LIFE 18 0.0013
197 TENDERNESS 13 0.0012
198 SKIN LESION 34 0.0012
199 SCRATCH 13 0.0012
200 BRONCHITIS CHRONIC 3 0.0012
201 EYE OEDEMA 3 0.0012
202 SKIN ATROPHY 7 0.0012
203 CHRONIC KIDNEY DISEASE 92 0.0012
204 SOCIAL PROBLEM 5 0.0012
205 PHARYNGITIS STREPTOCOCCAL 13 0.0012
206 SEASONAL ALLERGY 17 0.0012
207 HIGH DENSITY LIPOPROTEIN DECREASED 4 0.0012
208 LYME DISEASE 4 0.0012
209 HYPERAMMONAEMIA 6 0.0012
210 SKIN MASS 8 0.0012
211 APPENDICITIS PERFORATED 3 0.0012
212 ANGLE CLOSURE GLAUCOMA 3 0.0012
213 LOW DENSITY LIPOPROTEIN INCREASED 9 0.0012
214 ONYCHOCLASIS 8 0.0012
215 LIPOMA 3 0.0012
216 PAIN OF SKIN 31 0.0012
217 CAROTID ARTERY STENOSIS 4 0.0011
218 MENISCUS INJURY 7 0.0011
219 GINGIVAL PAIN 9 0.0011
220 CONJUNCTIVAL HYPERAEMIA 4 0.0011
221 CHEILITIS 6 0.0011
222 VASCULAR DEVICE INFECTION 5 0.0011
223 APPLICATION SITE HAEMORRHAGE 3 0.0011
224 PRODUCT DOSE OMISSION IN ERROR 31 0.0011
225 BASAL CELL CARCINOMA 17 0.0011
226 UMBILICAL HERNIA 5 0.0011
227 SQUAMOUS CELL CARCINOMA 10 0.0011
228 AUTOIMMUNE THYROIDITIS 4 0.0011
229 RASH PRURITIC 57 0.0011
230 FOLLICULITIS 11 0.0010
231 DISCOMFORT 64 0.0010
232 EYE SWELLING 39 0.0010
233 EYE INFLAMMATION 10 0.0010
234 ANAEMIA 199 0.0010
235 RALES 6 0.0010
236 ORAL HERPES 20 0.0010
237 GROWTH RETARDATION 3 0.0010
238 SKIN ODOUR ABNORMAL 4 0.0010
239 LARGE INTESTINE POLYP 7 0.0010
240 LUNG ADENOCARCINOMA 3 0.0010
241 WEIGHT DECREASED 278 0.0010
242 ERYSIPELAS 5 0.0010
243 CENTRAL VENOUS CATHETERISATION 3 0.0010
244 TOOTH INFECTION 13 0.0010
245 DECUBITUS ULCER 8 0.0010
246 PERIPHERAL VENOUS DISEASE 4 0.0010
247 TRIGGER FINGER 4 0.0010
248 SLEEP DISORDER 69 0.0010
249 THERAPEUTIC RESPONSE DECREASED 59 0.0010
250 APPLICATION SITE EXFOLIATION 4 0.0010
251 THERAPEUTIC RESPONSE SHORTENED 32 0.0010
252 ABDOMINAL PAIN 223 0.0010
253 BLOOD CREATININE DECREASED 3 0.0010
254 NEOPLASM 11 0.0010
255 CONSTIPATION 208 0.0010
256 MULTIPLE INJURIES 6 0.0010
257 BLADDER PAIN 3 0.0009
258 ARTHROPOD BITE 7 0.0009
259 ESCHERICHIA URINARY TRACT INFECTION 4 0.0009
260 PRURITUS 361 0.0009
261 LOOSE TOOTH 3 0.0009
262 PSYCHOLOGICAL TRAUMA 8 0.0009
263 HERPES SIMPLEX 6 0.0009
264 HEPATOCELLULAR CARCINOMA 7 0.0009
265 DRUG INEFFECTIVE 1209 0.0009
266 RASH MACULAR 32 0.0009
267 NAIL DISORDER 8 0.0009
268 ASTHENOPIA 5 0.0009
269 APPLICATION SITE PAIN 20 0.0009
270 HYPERKERATOSIS 5 0.0009
271 LIGAMENT RUPTURE 4 0.0009
272 EYE IRRITATION 52 0.0009
273 PRODUCT ADMINISTRATION INTERRUPTED 7 0.0009
274 SLEEP APNOEA SYNDROME 17 0.0009
275 IRON DEFICIENCY 4 0.0009
276 PYREXIA 307 0.0009
277 EYE INFECTION 10 0.0009
278 EXOSTOSIS 8 0.0009
279 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
280 FUNCTIONAL GASTROINTESTINAL DISORDER 3 0.0009
281 AORTIC STENOSIS 3 0.0009
282 ECONOMIC PROBLEM 13 0.0009
283 SPINAL COLUMN STENOSIS 4 0.0008
284 HAND FRACTURE 6 0.0008
285 INTERCEPTED PRODUCT STORAGE ERROR 3 0.0008
286 SQUAMOUS CELL CARCINOMA OF SKIN 5 0.0008
287 MONOCYTE COUNT INCREASED 3 0.0008
288 RASH PUSTULAR 6 0.0008
289 LIGAMENT SPRAIN 8 0.0008
290 HYPERNATRAEMIA 4 0.0008
291 SPINAL OSTEOARTHRITIS 7 0.0008
292 PEMPHIGOID 6 0.0008
293 DERMATITIS ALLERGIC 10 0.0008
294 LYMPHADENOPATHY 28 0.0008
295 EAR INFECTION 21 0.0008
296 INCORRECT PRODUCT ADMINISTRATION DURATION 17 0.0008
297 ROTATOR CUFF SYNDROME 10 0.0008
298 RASH 339 0.0008
299 BENIGN PROSTATIC HYPERPLASIA 4 0.0008
300 RASH ERYTHEMATOUS 37 0.0008
301 FAECES HARD 3 0.0008
302 FAILURE TO THRIVE 4 0.0008
303 END STAGE RENAL DISEASE 14 0.0008
304 HIDRADENITIS 7 0.0008
305 LACRIMATION INCREASED 23 0.0008
306 IMMUNE SYSTEM DISORDER 10 0.0008
307 RASH PAPULAR 17 0.0008
308 BACTERAEMIA 9 0.0008
309 UPPER RESPIRATORY TRACT INFECTION 35 0.0008
310 INTERVERTEBRAL DISC DEGENERATION 7 0.0008
311 HYPERPHAGIA 3 0.0008
312 COMPRESSION FRACTURE 4 0.0007
313 ARTERIOSCLEROSIS 7 0.0007
314 FUNGAL SKIN INFECTION 3 0.0007
315 ENURESIS 3 0.0007
316 CORONARY ARTERY OCCLUSION 10 0.0007
317 OSTEOPENIA 11 0.0007
318 LYMPHOEDEMA 5 0.0007
319 ANHEDONIA 19 0.0007
320 NERVE INJURY 8 0.0007
321 TREATMENT FAILURE 59 0.0007
322 VITREOUS FLOATERS 7 0.0007
323 REBOUND EFFECT 8 0.0007
324 PERIORBITAL SWELLING 4 0.0007
325 AORTIC VALVE INCOMPETENCE 3 0.0007
326 ABSCESS LIMB 3 0.0007
327 DIVERTICULUM 5 0.0007
328 METASTATIC NEOPLASM 3 0.0007
329 MOUTH SWELLING 4 0.0007
330 CHAPPED LIPS 3 0.0007
331 DYSPHEMIA 3 0.0007
332 UTERINE LEIOMYOMA 5 0.0007
333 HYPERTRIGLYCERIDAEMIA 4 0.0007
334 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
335 GLUCOSE TOLERANCE IMPAIRED 4 0.0007
336 SKIN DISCOLOURATION 31 0.0007
337 CATARACT OPERATION 4 0.0007
338 IMPLANT SITE PAIN 3 0.0007
339 SUNBURN 5 0.0007
340 SKIN BURNING SENSATION 48 0.0007
341 VENTRICULAR TACHYCARDIA 11 0.0007
342 ABDOMINAL HERNIA 3 0.0007
343 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
344 RETINAL DETACHMENT 6 0.0007
345 CARDIOMEGALY 8 0.0006
346 LYMPHOMA 10 0.0006
347 SCOLIOSIS 4 0.0006
348 OEDEMA 35 0.0006
349 MALAISE 283 0.0006
350 PAIN 394 0.0006
351 INTERVERTEBRAL DISC PROTRUSION 14 0.0006
352 MULTIPLE ALLERGIES 5 0.0006
353 SINUSITIS 65 0.0006
354 CORONARY ARTERY DISEASE 19 0.0006
355 ORAL PAIN 14 0.0006
356 PROCTALGIA 4 0.0006
357 HYPERCHOLESTEROLAEMIA 6 0.0006
358 ATELECTASIS 6 0.0006
359 RHINITIS 5 0.0006
360 EAR PAIN 12 0.0006
361 THIRST 11 0.0006
362 CELLULITIS 31 0.0006
363 EATING DISORDER 13 0.0006
364 APPLICATION SITE BURN 3 0.0006
365 BREATH SOUNDS ABNORMAL 3 0.0006
366 UPPER-AIRWAY COUGH SYNDROME 5 0.0006
367 SINUS DISORDER 12 0.0006
368 APPETITE DISORDER 4 0.0006
369 DERMATITIS EXFOLIATIVE 3 0.0006
370 BREAST MASS 4 0.0006
371 INFUSION SITE ERYTHEMA 5 0.0006
372 DYSPHORIA 3 0.0006
373 POSTOPERATIVE WOUND INFECTION 4 0.0006
374 TOOTH ABSCESS 6 0.0006
375 HIP ARTHROPLASTY 9 0.0006
376 SKIN HYPERPIGMENTATION 5 0.0006
377 INFLAMMATION 30 0.0006
378 JOINT EFFUSION 4 0.0006
379 CARDIAC MURMUR 5 0.0006
380 PRODUCT USE IN UNAPPROVED INDICATION 143 0.0006
381 THERAPY PARTIAL RESPONDER 9 0.0006
382 STAPHYLOCOCCAL INFECTION 19 0.0006
383 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
384 GLAUCOMA 11 0.0006
385 INJECTION SITE DISCOMFORT 6 0.0006
386 BURNING SENSATION 40 0.0006
387 SPINAL OPERATION 7 0.0006
388 INCONTINENCE 6 0.0006
389 BRONCHITIS 42 0.0006
390 CLOSTRIDIUM DIFFICILE COLITIS 6 0.0006
391 DRUG ERUPTION 10 0.0006
392 HAEMORRHOIDS 11 0.0006
393 BODY HEIGHT DECREASED 6 0.0006
394 FEAR OF INJECTION 4 0.0006
395 GASTROINTESTINAL INFECTION 5 0.0006
396 GOUT 10 0.0006
397 RENAL FAILURE 74 0.0006
398 MYOSITIS 5 0.0006
399 BRUXISM 3 0.0006
400 GINGIVITIS 3 0.0006
401 OROPHARYNGEAL DISCOMFORT 5 0.0006
402 DERMATITIS BULLOUS 4 0.0006
403 OSTEOMYELITIS 10 0.0006
404 LIP DRY 5 0.0005
405 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
406 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
407 PRODUCT DISTRIBUTION ISSUE 5 0.0005
408 PULMONARY MASS 8 0.0005
409 NEPHROPATHY 5 0.0005
410 MIDDLE INSOMNIA 10 0.0005
411 MACULAR OEDEMA 3 0.0005
412 APPENDICITIS 5 0.0005
413 FACE OEDEMA 9 0.0005
414 TUBULOINTERSTITIAL NEPHRITIS 10 0.0005
415 EYE PAIN 30 0.0005
416 PHOTOPHOBIA 10 0.0005
417 LACERATION 5 0.0005
418 NASAL CONGESTION 31 0.0005
419 TOXIC EPIDERMAL NECROLYSIS 8 0.0005
420 MALIGNANT MELANOMA 7 0.0005
421 HEADACHE 327 0.0005
422 METASTASES TO LUNG 6 0.0005
423 TENDONITIS 8 0.0005
424 CONCUSSION 4 0.0005
425 ELECTROLYTE IMBALANCE 6 0.0005
426 INFLAMMATORY BOWEL DISEASE 5 0.0005
427 VIRAL INFECTION 17 0.0005
428 BONE DENSITY DECREASED 16 0.0005
429 KIDNEY INFECTION 10 0.0005
430 DECREASED IMMUNE RESPONSIVENESS 5 0.0005
431 APPLICATION SITE RASH 7 0.0005
432 CYANOSIS 8 0.0005
433 URTICARIA 85 0.0005
434 BLOOD IRON DECREASED 6 0.0005
435 BLOOD ALBUMIN DECREASED 4 0.0005
436 PRODUCT PRESCRIBING ERROR 12 0.0005
437 ORAL DISCOMFORT 7 0.0005
438 CARDIAC PACEMAKER INSERTION 3 0.0005
439 HYPERLIPIDAEMIA 6 0.0005
440 WRIST FRACTURE 6 0.0005
441 OVARIAN CYST 5 0.0005
442 RESPIRATORY TRACT INFECTION 13 0.0005
443 PNEUMOCYSTIS JIROVECII PNEUMONIA 5 0.0005
444 GANGRENE 3 0.0005
445 TOOTHACHE 9 0.0005
446 TOXIC SKIN ERUPTION 5 0.0005
447 DERMATITIS ACNEIFORM 3 0.0005
448 THERAPY NON-RESPONDER 22 0.0005
449 OFF LABEL USE 428 0.0005
450 HYPERSOMNIA 14 0.0005
451 ABNORMAL FAECES 4 0.0005
452 EMOTIONAL DISTRESS 59 0.0005
453 GENERALISED OEDEMA 6 0.0005
454 PHARYNGITIS 6 0.0005
455 BACTERIAL INFECTION 9 0.0005
456 FEBRILE NEUTROPENIA 32 0.0005
457 INFUSION SITE EXTRAVASATION 3 0.0005
458 NAUSEA 381 0.0005
459 PULMONARY HYPERTENSION 10 0.0005
460 GASTROENTERITIS 7 0.0005
461 SECRETION DISCHARGE 6 0.0005
462 NASAL DRYNESS 3 0.0005
463 LIMB INJURY 13 0.0005
464 WEIGHT FLUCTUATION 5 0.0005
465 SWELLING FACE 31 0.0005
466 OROPHARYNGEAL PAIN 44 0.0005
467 FULL BLOOD COUNT ABNORMAL 5 0.0005
468 RENAL INJURY 14 0.0005
469 ARTHRITIS 37 0.0005
470 IRRITABLE BOWEL SYNDROME 10 0.0005
471 INJECTION SITE REACTION 32 0.0005
472 MYOPATHY 4 0.0005
473 PYELONEPHRITIS 4 0.0005
474 PLATELET COUNT INCREASED 6 0.0005
475 NODULE 6 0.0005
476 OESOPHAGITIS 5 0.0005
477 WOUND INFECTION 5 0.0005
478 EYE DISORDER 15 0.0005
479 GROIN PAIN 4 0.0005
480 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 82 0.0005
481 ALOPECIA 89 0.0005
482 LUNG INFILTRATION 4 0.0005
483 DENTAL CARIES 5 0.0005
484 CONDITION AGGRAVATED 137 0.0005
485 HAIR TEXTURE ABNORMAL 6 0.0004
486 INFLUENZA 50 0.0004
487 OSTEOARTHRITIS 19 0.0004
488 CHOLECYSTITIS CHRONIC 3 0.0004
489 INJECTION SITE PRURITUS 30 0.0004
490 JOINT RANGE OF MOTION DECREASED 6 0.0004
491 BRONCHIECTASIS 3 0.0004
492 FISTULA 5 0.0004
493 SINUS CONGESTION 6 0.0004
494 GASTROENTERITIS VIRAL 8 0.0004
495 UVEITIS 6 0.0004
496 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
497 CROHN'S DISEASE 3 0.0004
498 ECCHYMOSIS 3 0.0004
499 RIB FRACTURE 9 0.0004
500 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 21 0.0004
501 SKIN IRRITATION 20 0.0004
502 TOOTH LOSS 9 0.0004
503 DIVERTICULITIS 12 0.0004
504 MUSCLE TIGHTNESS 7 0.0004
505 BACK DISORDER 7 0.0004
506 SKIN REACTION 6 0.0004
507 ABORTION INDUCED 4 0.0004
508 EXPOSURE VIA SKIN CONTACT 11 0.0004
509 INJECTION SITE RASH 13 0.0004
510 SPINAL DISORDER 4 0.0004
511 FOOT FRACTURE 8 0.0004
512 SKIN CANCER 9 0.0004
513 CANDIDA INFECTION 7 0.0004
514 LOCALISED INFECTION 10 0.0004
515 OSTEOPOROSIS 17 0.0004
516 FAECES SOFT 3 0.0004
517 ACUTE KIDNEY INJURY 63 0.0004
518 LIQUID PRODUCT PHYSICAL ISSUE 3 0.0004
519 PLEURAL EFFUSION 25 0.0004
520 HEAD INJURY 13 0.0004
521 NEUROPATHY PERIPHERAL 39 0.0004
522 RENAL TUBULAR NECROSIS 4 0.0004
523 INJECTION SITE URTICARIA 10 0.0004
524 DYSURIA 15 0.0004
525 ANGIOEDEMA 18 0.0004
526 OSTEONECROSIS OF JAW 10 0.0004
527 CATARACT 24 0.0004
528 PERIPHERAL SWELLING 62 0.0004
529 HAIR COLOUR CHANGES 5 0.0004
530 TOOTH EXTRACTION 5 0.0004
531 UPPER LIMB FRACTURE 8 0.0004
532 HERPES ZOSTER 23 0.0004
533 PEMPHIGUS 5 0.0004
534 INTENTIONAL PRODUCT USE ISSUE 35 0.0004
535 BONE LOSS 6 0.0004
536 MIGRAINE 38 0.0004
537 HYPOAESTHESIA ORAL 6 0.0004
538 ILLNESS 41 0.0004
539 PRODUCT DOSE OMISSION ISSUE 117 0.0004
540 APPLICATION SITE PRURITUS 9 0.0004
541 OSTEONECROSIS 13 0.0004
542 SWELLING 37 0.0004
543 WOUND 11 0.0004
544 DRUG LEVEL DECREASED 4 0.0004
545 INSURANCE ISSUE 6 0.0004
546 SURGERY 23 0.0004
547 GALLBLADDER DISORDER 7 0.0004
548 NEUTROPHIL COUNT INCREASED 4 0.0004
549 INITIAL INSOMNIA 4 0.0004
550 EAR DISCOMFORT 4 0.0004
551 INJECTION SITE WARMTH 8 0.0004
552 FOOD ALLERGY 3 0.0004
553 INFUSION SITE PAIN 5 0.0004
554 INJECTION SITE PAIN 119 0.0004
555 TEMPERATURE INTOLERANCE 4 0.0004
556 INFECTION 56 0.0004
557 HIATUS HERNIA 5 0.0004
558 EJECTION FRACTION DECREASED 6 0.0004
559 BEDRIDDEN 5 0.0004
560 GASTRITIS 10 0.0004
561 INJECTION SITE SWELLING 29 0.0004
562 ATRIAL FLUTTER 3 0.0004
563 RETCHING 8 0.0004
564 JOINT INJURY 8 0.0004
565 BLOOD DISORDER 3 0.0004
566 ASCITES 11 0.0004
567 MOVEMENT DISORDER 12 0.0004
568 MUSCLE DISORDER 3 0.0004
569 PRURITUS GENERALISED 8 0.0004
570 ATRIAL FIBRILLATION 36 0.0004
571 URINARY TRACT INFECTION 63 0.0004
572 BLOOD URINE PRESENT 7 0.0004
573 SKIN LACERATION 4 0.0004
574 BACK INJURY 4 0.0004
575 WHITE BLOOD CELL COUNT INCREASED 14 0.0004
576 ASTHMA 41 0.0004
577 LIVER DISORDER 16 0.0004
578 ARTHROPATHY 20 0.0004
579 DYSPHONIA 21 0.0004
580 MALNUTRITION 4 0.0004
581 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
582 OCULAR DISCOMFORT 4 0.0004
583 PRODUCTIVE COUGH 17 0.0004
584 DEPRESSION 81 0.0004
585 IMPAIRED DRIVING ABILITY 4 0.0004
586 GASTROOESOPHAGEAL REFLUX DISEASE 28 0.0003
587 MUSCLE STRAIN 3 0.0003
588 MENTAL DISORDER 15 0.0003
589 HYPOTHYROIDISM 11 0.0003
590 BODY TEMPERATURE INCREASED 7 0.0003
591 PRODUCT PREPARATION ERROR 7 0.0003
592 COVID-19 PNEUMONIA 4 0.0003
593 PAIN IN EXTREMITY 99 0.0003
594 CHOLELITHIASIS 11 0.0003
595 ABDOMINAL DISTENSION 35 0.0003
596 WITHDRAWAL SYNDROME 14 0.0003
597 BLOOD POTASSIUM DECREASED 10 0.0003
598 EXPIRED PRODUCT ADMINISTERED 11 0.0003
599 UNEVALUABLE EVENT 25 0.0003
600 BLOOD COUNT ABNORMAL 5 0.0003
601 BURSITIS 4 0.0003
602 NOCTURIA 4 0.0003
603 BONE DISORDER 6 0.0003
604 ABDOMINAL DISCOMFORT 55 0.0003
605 NEPHROLITHIASIS 15 0.0003
606 INCREASED TENDENCY TO BRUISE 3 0.0003
607 IRON DEFICIENCY ANAEMIA 3 0.0003
608 DEVICE RELATED INFECTION 5 0.0003
609 ARTHRALGIA 135 0.0003
610 EMOTIONAL DISORDER 10 0.0003
611 TENDON RUPTURE 4 0.0003
612 BALANCE DISORDER 28 0.0003
613 ANKLE FRACTURE 5 0.0003
614 HEPATIC ENCEPHALOPATHY 3 0.0003
615 APPLICATION SITE IRRITATION 4 0.0003
616 PNEUMONIA 104 0.0003
617 DRUG INTOLERANCE 31 0.0003
618 BRAIN FOG 5 0.0003
619 BRAIN OEDEMA 4 0.0003
620 STEVENS-JOHNSON SYNDROME 7 0.0003
621 RED BLOOD CELL COUNT DECREASED 9 0.0003
622 INJECTION SITE IRRITATION 4 0.0003
623 PRODUCT USE ISSUE 59 0.0003
624 OBESITY 5 0.0003
625 THERAPEUTIC PRODUCT EFFECT DECREASED 14 0.0003
626 AFFECT LABILITY 3 0.0003
627 INSOMNIA 83 0.0003
628 CONTUSION 30 0.0003
629 NIGHT SWEATS 10 0.0003
630 HERNIA 6 0.0003
631 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 17 0.0003
632 PLATELET COUNT DECREASED 33 0.0003
633 NASOPHARYNGITIS 57 0.0003
634 INJECTION SITE INDURATION 4 0.0003
635 BLOOD PRESSURE SYSTOLIC INCREASED 6 0.0003
636 EPISTAXIS 23 0.0003
637 DEAFNESS 8 0.0003
638 APPLICATION SITE ERYTHEMA 8 0.0003
639 PARAESTHESIA 48 0.0003
640 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
641 BLISTER 17 0.0003
642 DIARRHOEA 194 0.0003
643 BRAIN INJURY 3 0.0003
644 VISION BLURRED 41 0.0003
645 CHILLS 35 0.0003
646 VISUAL IMPAIRMENT 37 0.0003
647 QUALITY OF LIFE DECREASED 4 0.0003
648 INJECTION SITE MASS 11 0.0003
649 PRODUCT PHYSICAL ISSUE 6 0.0003
650 DRY THROAT 3 0.0003
651 IMPAIRED GASTRIC EMPTYING 4 0.0003
652 COUGH 82 0.0003
653 HAEMATURIA 10 0.0003
654 ANXIETY 83 0.0003
655 PRODUCT DOSE OMISSION 19 0.0003
656 THERAPEUTIC RESPONSE UNEXPECTED 13 0.0003
657 INCORRECT DOSE ADMINISTERED 66 0.0003
658 INJECTION SITE BRUISING 23 0.0003
659 POLLAKIURIA 12 0.0003
660 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
661 COORDINATION ABNORMAL 4 0.0003
662 FATIGUE 223 0.0003
663 PANCYTOPENIA 16 0.0003
664 EOSINOPHILIA 5 0.0003
665 BACK PAIN 66 0.0003
666 BLOOD TRIGLYCERIDES INCREASED 5 0.0003
667 SYSTEMIC LUPUS ERYTHEMATOSUS 10 0.0003
668 IMPAIRED WORK ABILITY 6 0.0003
669 HYPERSENSITIVITY 52 0.0003
670 OEDEMA PERIPHERAL 34 0.0003
671 POOR QUALITY SLEEP 6 0.0003
672 HOT FLUSH 21 0.0003
673 DECREASED ACTIVITY 3 0.0003
674 ACNE 21 0.0003
675 GAIT DISTURBANCE 53 0.0003
676 PRODUCT PRESCRIBING ISSUE 6 0.0003
677 PANIC ATTACK 10 0.0003
678 INJECTION SITE ERYTHEMA 34 0.0003
679 MUSCULOSKELETAL STIFFNESS 24 0.0003
680 ASPIRATION 3 0.0003
681 CARDIAC FAILURE CONGESTIVE 22 0.0003
682 GASTROINTESTINAL PAIN 3 0.0003
683 SKIN ULCER 7 0.0003
684 FOOT DEFORMITY 3 0.0003
685 CARDIOMYOPATHY 4 0.0003
686 HAEMATOMA 7 0.0003
687 FUNGAL INFECTION 9 0.0003
688 TOOTH DISORDER 6 0.0003
689 URINARY RETENTION 9 0.0003
690 HEPATIC STEATOSIS 5 0.0003
691 COLON CANCER 4 0.0003
692 INFLUENZA LIKE ILLNESS 22 0.0003
693 INTESTINAL PERFORATION 3 0.0003
694 HEPATIC CIRRHOSIS 5 0.0003
695 INTESTINAL OBSTRUCTION 10 0.0003
696 BLOOD SODIUM DECREASED 5 0.0003
697 FLATULENCE 15 0.0003
698 MOBILITY DECREASED 19 0.0003
699 RHINORRHOEA 17 0.0003
700 CHOLECYSTECTOMY 3 0.0003
701 FEELING JITTERY 5 0.0003
702 DIABETES MELLITUS 20 0.0003
703 MUSCLE SPASMS 48 0.0003
704 THROMBOSIS 21 0.0003
705 POST PROCEDURAL COMPLICATION 5 0.0003
706 HOSPITALISATION 40 0.0003
707 MUSCLE TWITCHING 6 0.0003
708 SEPSIS 29 0.0003
709 SYNCOPE 26 0.0003
710 PERICARDIAL EFFUSION 6 0.0003
711 MATERNAL EXPOSURE DURING PREGNANCY 23 0.0003
712 BLOOD CHOLESTEROL INCREASED 12 0.0003
713 COVID-19 45 0.0003
714 INJURY 18 0.0003
715 PRODUCT USE COMPLAINT 4 0.0003
716 RESPIRATORY DISTRESS 7 0.0003
717 THERAPY CESSATION 13 0.0003
718 HAEMOGLOBIN DECREASED 26 0.0003
719 PULMONARY EMBOLISM 24 0.0003
720 FALL 84 0.0003
721 DISEASE RECURRENCE 12 0.0003
722 PNEUMOTHORAX 4 0.0003
723 HAEMATOCRIT DECREASED 5 0.0003
724 CHOLECYSTITIS 3 0.0003
725 RESPIRATORY TRACT CONGESTION 4 0.0003
726 FEELING COLD 7 0.0003
727 CYSTITIS 8 0.0003
728 SCIATICA 4 0.0003
729 PREGNANCY 5 0.0002
730 SPINAL FRACTURE 5 0.0002
731 CRYING 9 0.0002
732 ADRENAL INSUFFICIENCY 3 0.0002
733 FIBROMYALGIA 6 0.0002
734 DRY MOUTH 20 0.0002
735 INTENTIONAL DOSE OMISSION 7 0.0002
736 NEUTROPHIL COUNT DECREASED 10 0.0002
737 CYTOPENIA 3 0.0002
738 IMPAIRED HEALING 8 0.0002
739 MANIA 4 0.0002
740 PHOTOSENSITIVITY REACTION 4 0.0002
741 CYST 3 0.0002
742 HYPERTENSION 51 0.0002
743 INJECTION SITE DISCOLOURATION 3 0.0002
744 COAGULOPATHY 4 0.0002
745 DYSSTASIA 7 0.0002
746 NEOPLASM MALIGNANT 16 0.0002
747 DYSPNOEA EXERTIONAL 9 0.0002
748 MUSCULAR WEAKNESS 27 0.0002
749 CHEST PAIN 44 0.0002
750 MOUTH ULCERATION 5 0.0002
751 ANGER 8 0.0002
752 URINARY INCONTINENCE 7 0.0002
753 HEPATIC CYTOLYSIS 3 0.0002
754 INTRAOCULAR PRESSURE INCREASED 3 0.0002
755 HYPOPHAGIA 6 0.0002
756 RESPIRATORY DISORDER 7 0.0002
757 SOMNOLENCE 47 0.0002
758 LIVER FUNCTION TEST INCREASED 5 0.0002
759 WEIGHT INCREASED 52 0.0002
760 HEART RATE INCREASED 23 0.0002
761 RASH GENERALISED 6 0.0002
762 FAECES DISCOLOURED 5 0.0002
763 SEPTIC SHOCK 10 0.0002
764 VERTIGO 14 0.0002
765 PRODUCT DISPENSING ERROR 5 0.0002
766 LOCAL SWELLING 4 0.0002
767 SEDATION 6 0.0002
768 JOINT STIFFNESS 6 0.0002
769 SYRINGE ISSUE 4 0.0002
770 ANKYLOSING SPONDYLITIS 3 0.0002
771 HYPOAESTHESIA 34 0.0002
772 LIMB DISCOMFORT 7 0.0002
773 ASTHENIA 85 0.0002
774 EYE HAEMORRHAGE 3 0.0002
775 JOINT SWELLING 27 0.0002
776 MYALGIA 38 0.0002
777 ABDOMINAL PAIN UPPER 46 0.0002
778 PULMONARY OEDEMA 10 0.0002
779 ACCIDENTAL EXPOSURE TO PRODUCT 23 0.0002
780 FEAR 6 0.0002
781 SNEEZING 5 0.0002
782 BLOOD PRESSURE INCREASED 34 0.0002
783 EXTRA DOSE ADMINISTERED 9 0.0002
784 SYNOVITIS 4 0.0002
785 THROAT TIGHTNESS 6 0.0002
786 DRUG EFFECT INCOMPLETE 8 0.0002
787 RESTLESS LEGS SYNDROME 4 0.0002
788 TREATMENT NONCOMPLIANCE 12 0.0002
789 IRRITABILITY 13 0.0002
790 MENTAL STATUS CHANGES 6 0.0002
791 HYPOMAGNESAEMIA 3 0.0002
792 DEEP VEIN THROMBOSIS 14 0.0002
793 HUNGER 3 0.0002
794 MASS 3 0.0002
795 CARPAL TUNNEL SYNDROME 3 0.0002
796 INCORRECT DRUG ADMINISTRATION DURATION 6 0.0002
797 CARDIAC FAILURE 17 0.0002
798 PROTEINURIA 4 0.0002
799 BRONCHOSPASM 3 0.0002
800 LIP SWELLING 7 0.0002
801 MUSCULOSKELETAL PAIN 11 0.0002
802 HYPOACUSIS 9 0.0002
803 DEPRESSED MOOD 11 0.0002
804 ACUTE RESPIRATORY FAILURE 4 0.0002
805 TYPE 2 DIABETES MELLITUS 7 0.0002
806 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
807 PRESCRIBED OVERDOSE 4 0.0002
808 HYPOKINESIA 3 0.0002
809 DIZZINESS 103 0.0002
810 NEUTROPENIA 28 0.0002
811 PALPITATIONS 24 0.0002
812 DRUG EFFECT DECREASED 11 0.0002
813 LABORATORY TEST ABNORMAL 6 0.0002
814 RENAL IMPAIRMENT 17 0.0002
815 BLOOD ALKALINE PHOSPHATASE INCREASED 5 0.0002
816 IMMUNODEFICIENCY 3 0.0002
817 BLOOD PRESSURE ABNORMAL 4 0.0002
818 THROAT IRRITATION 9 0.0002
819 AGEUSIA 5 0.0002
820 PNEUMONIA ASPIRATION 5 0.0002
821 DRUG DOSE OMISSION 33 0.0002
822 HYPOXIA 7 0.0002
823 CONTRAINDICATED PRODUCT ADMINISTERED 6 0.0002
824 GLYCOSYLATED HAEMOGLOBIN INCREASED 5 0.0002
825 DECREASED APPETITE 46 0.0002
826 STOMATITIS 12 0.0002
827 DYSPNOEA 112 0.0002
828 NECK PAIN 11 0.0002
829 CHEST DISCOMFORT 20 0.0002
830 HYPONATRAEMIA 11 0.0002
831 MUSCULOSKELETAL CHEST PAIN 3 0.0002
832 UNRESPONSIVE TO STIMULI 5 0.0002
833 RENAL DISORDER 9 0.0002
834 LUNG INFECTION 3 0.0002
835 DIPLOPIA 5 0.0002
836 HAEMORRHAGE 20 0.0002
837 KNEE ARTHROPLASTY 4 0.0002
838 GASTROINTESTINAL DISORDER 17 0.0002
839 ABSCESS 3 0.0002
840 DYSARTHRIA 7 0.0002
841 WHEEZING 11 0.0002
842 VOMITING 87 0.0002
843 BLOOD POTASSIUM INCREASED 3 0.0002
844 VAGINAL HAEMORRHAGE 8 0.0002
845 PNEUMONITIS 5 0.0002
846 CLOSTRIDIUM DIFFICILE INFECTION 4 0.0002
847 MULTIPLE FRACTURES 3 0.0002
848 MEMORY IMPAIRMENT 25 0.0002
849 VISUAL ACUITY REDUCED 6 0.0002
850 FEELING HOT 11 0.0002
851 PLASMA CELL MYELOMA 7 0.0002
852 PANCREATITIS ACUTE 4 0.0002
853 OXYGEN SATURATION DECREASED 10 0.0002
854 DISEASE PROGRESSION 21 0.0002
855 HEART RATE IRREGULAR 4 0.0002
856 EXPOSURE DURING PREGNANCY 11 0.0002
857 ABNORMAL BEHAVIOUR 7 0.0002
858 HEPATIC ENZYME INCREASED 12 0.0002
859 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
860 INJECTION SITE HAEMORRHAGE 14 0.0002
861 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
862 SUICIDAL IDEATION 16 0.0002
863 MUSCULOSKELETAL DISCOMFORT 3 0.0002
864 HYPOKALAEMIA 8 0.0002
865 DEHYDRATION 23 0.0002
866 LIVER FUNCTION TEST ABNORMAL 5 0.0002
867 BLINDNESS 7 0.0002
868 COGNITIVE DISORDER 8 0.0002
869 FEELING ABNORMAL 41 0.0002
870 HEART RATE DECREASED 6 0.0002
871 BONE PAIN 10 0.0002
872 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
873 DIABETES MELLITUS INADEQUATE CONTROL 3 0.0002
874 PSYCHOTIC DISORDER 5 0.0002
875 ISCHAEMIC STROKE 3 0.0002
876 MULTIPLE SCLEROSIS 8 0.0002
877 LEUKOCYTOSIS 3 0.0002
878 SEIZURE 19 0.0002
879 RESTLESSNESS 6 0.0002
880 ABASIA 4 0.0002
881 DYSGEUSIA 12 0.0002
882 HYPOCALCAEMIA 3 0.0002
883 MUSCULOSKELETAL DISORDER 3 0.0002
884 CARDIOVASCULAR DISORDER 4 0.0002
885 FLUSHING 16 0.0002
886 INCREASED APPETITE 3 0.0002
887 MOOD SWINGS 5 0.0002
888 METABOLIC ACIDOSIS 5 0.0002
889 HEPATITIS 4 0.0002
890 DRUG PRESCRIBING ERROR 3 0.0002
891 ERECTILE DYSFUNCTION 4 0.0002
892 ERUCTATION 3 0.0002
893 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 11 0.0002
894 BLOOD CREATININE INCREASED 10 0.0002
895 MENORRHAGIA 3 0.0002
896 SPEECH DISORDER 8 0.0002
897 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
898 TINNITUS 7 0.0002
899 DISABILITY 3 0.0002
900 ABORTION SPONTANEOUS 6 0.0001
901 CARDIAC DISORDER 14 0.0001
902 GAIT INABILITY 5 0.0001
903 INTENTIONAL PRODUCT MISUSE 13 0.0001
904 DYSKINESIA 6 0.0001
905 HYPERHIDROSIS 19 0.0001
906 PALLOR 4 0.0001
907 MOOD ALTERED 4 0.0001
908 GASTRIC DISORDER 5 0.0001
909 ABNORMAL DREAMS 4 0.0001
910 ADVERSE DRUG REACTION 13 0.0001
911 NIGHTMARE 5 0.0001
912 HYPOGLYCAEMIA 7 0.0001
913 ROAD TRAFFIC ACCIDENT 6 0.0001
914 PAIN IN JAW 4 0.0001
915 RHEUMATOID ARTHRITIS 16 0.0001
916 LOSS OF CONSCIOUSNESS 18 0.0001
917 THERAPY INTERRUPTED 10 0.0001
918 PANCREATIC CARCINOMA 4 0.0001
919 HYPERGLYCAEMIA 5 0.0001
920 RESPIRATORY FAILURE 10 0.0001
921 MELAENA 3 0.0001
922 GLOSSODYNIA 3 0.0001
923 NERVOUSNESS 7 0.0001
924 CARDIAC ARREST 11 0.0001
925 CHROMATURIA 3 0.0001
926 HALLUCINATION 10 0.0001
927 APHASIA 4 0.0001
928 BRADYCARDIA 7 0.0001
929 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
930 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
931 DISTURBANCE IN ATTENTION 7 0.0001
932 GENERAL PHYSICAL HEALTH DETERIORATION 15 0.0001
933 SWOLLEN TONGUE 4 0.0001
934 DRUG-INDUCED LIVER INJURY 4 0.0001
935 ANAPHYLACTIC REACTION 7 0.0001
936 DYSPHAGIA 12 0.0001
937 DISORIENTATION 5 0.0001
938 THROMBOCYTOPENIA 14 0.0001
939 BLOOD GLUCOSE DECREASED 6 0.0001
940 DIABETIC KETOACIDOSIS 3 0.0001
941 TACHYCARDIA 11 0.0001
942 MENTAL IMPAIRMENT 3 0.0001
943 CEREBRAL INFARCTION 3 0.0001
944 ENCEPHALOPATHY 3 0.0001
945 LETHARGY 7 0.0001
946 TREMOR 20 0.0001
947 BLOOD PRESSURE DECREASED 8 0.0001
948 LEUKOPENIA 6 0.0001
949 CARDIO-RESPIRATORY ARREST 5 0.0001
950 BREAST CANCER 11 0.0001
951 FLUID RETENTION 6 0.0001
952 CONFUSIONAL STATE 19 0.0001
953 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 3 0.0001
954 HYPOTENSION 23 0.0001
955 HYPERKALAEMIA 4 0.0001
956 ALANINE AMINOTRANSFERASE INCREASED 7 0.0001
957 DRUG WITHDRAWAL SYNDROME 10 0.0001
958 PANCREATITIS 6 0.0001
959 MENSTRUATION IRREGULAR 3 0.0001
960 INCORRECT ROUTE OF DRUG ADMINISTRATION 4 0.0001
961 DEVICE ISSUE 10 0.0001
962 C-REACTIVE PROTEIN INCREASED 4 0.0001
963 UNDERDOSE 8 0.0001
964 MYOCARDIAL INFARCTION 19 0.0001
965 GASTROINTESTINAL HAEMORRHAGE 9 0.0001
966 DRUG INTERACTION 17 0.0001
967 MULTIPLE ORGAN DYSFUNCTION SYNDROME 3 0.0001
968 DEATH 90 0.0001
969 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 21 0.0001
970 PRODUCT QUALITY ISSUE 14 0.0001
971 ACUTE MYOCARDIAL INFARCTION 3 0.0001
972 AGGRESSION 5 0.0001
973 HEPATIC FAILURE 3 0.0001
974 BLOOD GLUCOSE INCREASED 18 0.0001
975 NO ADVERSE EVENT 17 0.0001
976 MEDICATION ERROR 5 0.0001
977 CEREBROVASCULAR ACCIDENT 15 0.0001
978 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
979 DRUG DEPENDENCE 14 0.0001
980 PRODUCT SUBSTITUTION ISSUE 5 0.0001
981 DEVICE MALFUNCTION 6 0.0001
982 AGITATION 6 0.0001
983 AMNESIA 5 0.0001
984 ADVERSE EVENT 7 0.0001
985 LUNG NEOPLASM MALIGNANT 3 0.0001
986 PRODUCT STORAGE ERROR 6 0.0001
987 OVERDOSE 11 0.0001
988 BLADDER CANCER 3 0.0001
989 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
990 MULTIPLE SCLEROSIS RELAPSE 3 0.0000
991 DRUG ABUSE 3 0.0000